+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition

  • Report
  • 593 Pages
  • April 2022
  • Region: Global
  • Kalorama Information
  • ID: 5315030
As discussed in this report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition, POC testing has skyrocketed in the last 20 years as demand for accurate and rapid testing has blossomed both inside and outside the hospital setting. An in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient’s home. The POC diagnostic industry will be part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine.


POC tests are performed in a wide range of geographical locations such as:

  • Hospital departments such as emergency departments, operating rooms, intensive care units, and others
  • Physicians’ offices
  • Hospital clinics
  • Rural health clinics
  • Student health clinics
  • Retail clinics
  • Pharmacies
  • Homes - With testing performed by patients, visiting nurses, or other caregivers
  • Nursing homes
  • Prisons

POC testing may be performed by laboratory personnel, but often it is performed by non-laboratory personnel such as physicians, nurses, assistants in medical offices, emergency medical technicians (EMTs), medics, pharmacists, and the patients themselves (self-testing). Some POC tests are manual tests, often performed with technologies based on dipsticks or strips, lateral flow cassettes, or other manual tests. There are also many small, portable instruments that have been developed for use in POC settings. With the advances in miniaturization and microfluidics that have occurred in recent years, a growing number of small, handheld devices are reaching the POC market for a range of different testing applications.

The menu for point-of-care testing continues to expand.  The traditional set of POC tests includes blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, hemoglobin diagnostics, infectious disease testing and cholesterol screening.

In the past 5-10 years the following tests were added: HbA1c, B-Type Natriuretic Peptide (BNP), whole-blood lactate, D-Dimer, C-Reactive Protein (CRP).

Moreover, POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use.  At the same time, more decentralized test venues invest in non-waived rapid tests and instruments.  POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care.  New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record. Rapid tests are beginning to fold into the point of care arena because they allow the physician to treat the patient before they leave the clinic or office.

This report breaks out point of care testing by segment.


Among the top and/or innovative competitors discussed within Corporate Profiles are:

  • 1 Step Detect Associates
  • Abbott Laboratories
  • Abingdon Health
  • Access Bio
  • AccuBioTech Co
  • ACON Laboratories
  • Aerscher Diagnostics
  • Akers Biosciences
  • Alfa Scientific Designs
  • American Bio Medica
  • ARKRAY
  • Artron Laboratories
  • Ascensia Diabetes Care
  • Ativa Medical Corp
  • Atlas Link Biotech
  • Audit Diagnostics
  • Autobio Diagnostics
  • Beckman Coulter
  • Becton Dickinson
  • Beijing Wantai Biological Pharmaceuticals
  • Bhat Bio-Tech India Private Ltd.
  • Binx health
  • bioLytical Laboratories
  • BioMedomics
  • Biomeme
  • Biomerica
  • bioMérieux SA
  • Bio-Rad Laboratories
  • Biosensia
  • Biotron Diagnostics
  • Boditech Med
  • Boson Biotech
  • BTNX
  • Calypte Biomedical Corp
  • Cepheid
  • Chembio Diagnostics
  • Church & Dwight
  • Clarity Diagnostics
  • Confirm Biosciences
  • CTK Biotech
  • Danaher Corporation
  • Dexcom
  • DIALAB
  • DiaSys Diagnostic Systems
  • Diazyme Laboratories
  • DNA Electronics Ltd. (DNAe)
  • Dr Fooke-Achterrath
  • DxGen
  • Eiken Chemical
  • EKF Diagnostics
  • ELITechGroup, Inc
  • Enterix (Clinical Genomics)
  • Eurobio Scientific
  • Everlywell
  • Exact Sciences
  • EY Laboratories
  • First Check Diagnostics
  • GenBio
  • Genedrive
  • GenePOC
  • GeTein Biotech Inc.
  • GlysBy
  • Helena Labs
  • Hemosure
  • HORIBA
  • Immunosciences Lab
  • Immunostics
  • Mitra & Co Pvt
  • JAL Innovation
  • Jant Pharmacal
  • LamdaGen Corp
  • LifeScan
  • LifeSign
  • LightDeck Diagnostics
  • Macherey-Nagel
  • Medix Biochemica
  • MedMira
  • Medtronic
  • Menarini Diagnostics
  • Meridian BioScience
  • MiCo BioMed USA
  • Nano-Ditech Corporation
  • NG Biotech
  • Noble Medical
  • Nova Biomedical
  • NuGenerex Diagnostics
  • Oasis Diagnostics
  • Operon
  • OPKO Health
  • OraSure Technologies
  • Polymedco
  • Polymer Technologies (PTS Diagnostics)
  • Preventis
  • Princeton Biomeditech
  • QuantuMDx Group
  • Quidel
  • Radiometer Medical
  • Randox Labs
  • RENESA UG
  • Response Biomedical
  • Reszon Diagnostics
  • Rheonix
  • Roche Diagnostics
  • Savyon Diagnostics
  • Sekisui Diagnostics
  • Siemens Healthcare
  • Sysmex
  • TECHLAB
  • Trinity Biotech
  • Trividia Health
  • Tulip Diagnostics
  • VedaLab
  • Veredus Laboratories
  • Werfen

Scope and Methodology


The geographic scope of The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition is global, with information for specific geographical regions, world demographics, and other general issues affecting the market. The market summary includes total market values, market analysis by product, test usage, technology, region, end-use and a competitive analysis of leading providers.  Additionally, key company profiles are included.

All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests excluding services.  The base year for data was 2021, including updates and reexaminations stemming from the impact of the COVID-19 pandemic. Forecast data is provided for 2022 through 2026. Compound annual growth rates (CAGRs) are provided for 2021-2026 periods for each segment covered.  Competitive analysis is provided for the year 2021 along with regional breakdowns.  The forecasted market analysis for 2022-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.

Table of Contents

Chapter 1: Executive Summary
  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
    • Table 1-1: Global POC Test Market, 2021-2026 (in millions $ at manufacturer level)
  • Trends Affecting the Market
  • POC COVID TESTING
  • Overview of POC COVID-19 Testing
  • Market Outlook
    • Figure 1-1: POC COVID-19 Testing Market by Method
  • Major Product Activity
  • Antigen (last six months)
  • Serology (last six months)
  • Molecular (last six months)
  • Setting Market
    • Figure 1-2: POC COVID-19 Sales by Test Setting, 2020 and 2021
  • Top Company Briefs
  • Abbott
  • Roche
  • Quidel
  • Becton Dickinson
    • Figure 1-3: Major Players in the POC COVID-19 Test Market, 2021
  • Competitive Outlook
  • Market Conclusions
  • Conclusion One - POC Market Transformed By Technological Progress
  • Conclusion Two - POC Molecular Diagnostics Continue Making Inroads
  • Conclusion Three - Prevention and Early Detection at Nexus of POC Development
  • Conclusion Four - Wearables Continue to Influence POC Market
  • Conclusion Four - Test Cost Will Continue to be an Issue Worldwide
  • Conclusion Five - Rising Demand Will Drive POC Market in RoW Markets
  • Conclusion Six - New venues - Urgent & Retail Care
  • Conclusion Seven - COVID-19’s Positive Effect
  • Conclusion Eight - Insurance Coverage for OTC  COVID-19 Testing
  • Conclusion Nine - New Opportunities in POC Infectious Disease Testing
  • Conclusion Ten - Supply Chain Delays

Chapter 2: Introduction and Overview
  • Point-of-Care Diagnostics Testing
  • Industry Regulations
  • POC Industry Drivers
  • Patient focused drivers
  • Medical/Healthcare related drivers
  • Technology drivers
  • Economic drivers
  • Other drivers
  • POC Industry Challenges
  • POC Test Types
  • Blood
  • Urine
  • Saliva
  • Hair
  • Optical Technologies
  • Breath
  • Conditions Evaluated by POC Diagnostic Testing
  • Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Cardiovascular Disease
  • Diabetes
  • Drug Abuse
  • Infectious Disease
  • Herpes
  • HTLV
  • Respiratory Syncytial Virus
  • Hepatitis
  • Lyme Disease
  • Babesiosis
  • Gonorrhea, Syphilis and Chlamydia
  • Trichomonas Vaginalis
  • HIV/AIDS
  • Helicobacter Pylori
  • Influenza
  • Coronavirus
  • Mononucleosis
  • Streptococcus
  • Osteoporosis
  • Pregnancy and Fertility

Chapter 3: POC Blood Glucose Tests
  • Types of Blood Glucose Testing
  • Fasting Blood Sugar (FBS)
  • 2-Hour Postprandial Blood Sugar (PPBS)
  • Random Blood Sugar
  • Glucose Tolerance Test
  • Glucose Urine Test
  • Glycated Hemoglobin (HbA1c)
  • Products
  • Blood Glucose Self-Testing
    • Table 3-1: Selected Glucose Self-Test Meter Innovations
    • Table 3-2: Selected Apps and Glucose Management IT
  • Continuous Self-Testing
  • Glycated Hemoglobin Tests
    • Table 3-3: Selected POC HbA1c Devices
  • Professional
  • Market Size and Growth
    • Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
    • Table 3-5:  Global POC Diabetes Sales by Test Category, 2021-2026 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC) (TOTAL; $ millions)
  • Regional Analysis
    • Figure 3-1: POC Blood Glucose Testing Regional Market Analysis, 2021 (%)
  • POC Glucose Self-Testing
    • Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices) 2021-2026 (in millions $ at manufacturer level)
  • POC Continuous Glucose Self-Testing
    • Table 3-7: Global POC Continuous Glucose Self-Testing Market 2021-2026 (in millions $ at manufacturer level)
  • POC Glucose Professional Testing
    • Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing) 2021-2026 (in millions $ at manufacturer level)
  • POC HbA1c Testing
    • Table 3-9: Global POC Glucose HbA1c Professional Testing Market 2021-2026 (in millions $ at manufacturer level)
  • COVID-19 Impact
  • Competitive Analysis
    • Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM, HbA1c) Revenues and Market Share of Leading Suppliers, 2021 (in millions $)
    • Figure 3-2: Global POC Glucose Test Manufacturers, by Percent, 2021

Chapter 4: POC Blood and Electrolytes Testing Market
  • Types of Blood and Electrolytes Tests
  • Hemoglobin/Hematocrit
  • WBC and Other
  • Blood Gases
  • Electrolytes
  • Products
    • Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2021
    • Table 4-2: Selected POC Hematology Analyzer Systems, 2021
  • Developments
  • Market Size and Growth
    • Table 4-3: Global POC Blood and Electrolytes Testing (Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC, Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
    • Table 4-4:  Global POC Blood & Electrolytes Revenues by Test Category, 2021-2026 ($ millions)
  • Regional Analysis
    • Figure 4-1: POC Blood and Electrolytes Testing Regional Market (US, Europe, Japan, Rest of World) Analysis 2021
  • POC Blood and Electrolyte Self-Testing
    • Table 4-5: Global POC Blood and Electrolyte Self Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • POC Blood and Electrolyte Professional Testing
    • Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
    • Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2021 (in millions $)
    • Figure 4-2: Global POC Blood and Electrolyte Testing Market Manufacturers, by Percent, 2021

Chapter 5: POC Rapid Coagulation
  • Products
    • Table 5-1: Selected POC Coagulation Test Innovations
  • Platelet Testing
    • Table 5-2: Selected Platelet Activity Test Innovations
  • Market Size and Growth
    • Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
    • Figure 5-1: POC Rapid Coagulation Testing Regional (US, Europe, Japan, Rest of World) Market Analysis 2021
  • POC Rapid Coagulation Self-Testing
    • Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • POC Rapid Coagulation Professional Testing
    • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
    • Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2021 (in millions$)
    • Figure 5-2: Global POC Rapid Coagulation Testing Market, Market Share % of Leading Suppliers, 2021

Chapter 6: POC Rapid Cardiac Markers
  • Products
  • Market Size and Growth
    • Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
    • Figure 6-1: POC Rapid Cardiac Markers Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2021
  • COVID-19 Impact
  • Competitive Analysis
    • Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2021 (in millions $)
    • Figure 6-2: Global POC Cardiac Test Manufacturers by Percent, 2021

Chapter 7: POC Substance Abuse
  • Overview
  • Products
  • Urine
  • Oral
  • Blood
  • Hair
  • Market Size and Growth
    • Table 7-1: Global POC Drugs of Abuse Testing (critical care, employment and criminal) Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
    • Figure 7-1: POC Substance Abuse Testing Regional (US, Europe, Japan, Rest of World)  Market Analysis, 2021 (%)
  • POC Drugs of Abuse Self-Testing
    • Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2021-2026 (in millions of dollars)
  • POC Drugs of Abuse Professional Testing
    • Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
    • Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2021 (in millions$)
    • Figure 7-2: Global POC Drug of Abuse Testing Manufacturers by Percent, 2021

Chapter 8: POC Pregnancy and Fertility Testing
  • Products
    • Table 8-1:  Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer’s Instrument / Device / Assay
  • Market Size and Growth
    • Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
    • Figure 8-1: POC Pregnancy and Fertility Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2021
  • POC Pregnancy and Fertility Self-Testing
    • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • POC Pregnancy and Fertility Professional Testing
    • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
    • Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2021 (in millions $)
    • Figure 8-2 Global POC Pregnancy and Fertility Testing Manufacturers by Percent, 2021

Chapter 9: POC Colon Cancer Screening/Fecal Occult Blood Testing
  • Products
    • Table 9-1: Selected POC Colon Cancer Tests
  • Market Size and Growth
    • Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2021-2026 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
    • Figure 9-1: POC Colon Cancer Screening/FOB Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2021
  • POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
    • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
    • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
    • Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2021 (in millions $)
    • Figure 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers by Percent, 2021

Chapter 10: POC Infectious Disease Testing
  • Products
  • HIV and Hepatitis
  • Respiratory
  • STD
  • Tropical Diseases
  • Lyme Disease
  • TB
  • Zika
  • Hospital Acquired Infections and Sepsis
  • Sepsis
  • C.Diff
    • Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics
  • COVID-19
  • Antigen
  • Serology
  • Molecular
  • Market Size and Growth
    • Table 10-2: Global POC Infectious Disease (including COVID-19) Testing Market Analysis: 2021-2026(in millions of dollars at the manufacturer’s level)
  • Regional Analysis
    • Figure 10-1: POC Infectious Disease (including COVID-19) Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2021
  • POC Infectious Disease Self-Testing
    • Table 10-3: POC Infectious Disease Self-Testing (including COVID-19) Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • POC Infectious Disease Professional Testing
    • Table 10-4: POC Infectious Disease (including COVID-19) Professional Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • POC Infectious Disease Testing by Disease Type
    • Table 10-5: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type, 2021 (in millions $)
    • Figure 10-2 : Global POC Infectious Disease (COVID-19, Influenza, HIV, STD, Hepatitis, Malaria, C. Diff, E. coli, H. pylori, Home, Others) Percent by Disease Type 2021
    • Figure 10-3: Global Selected POC Infectious Disease (COVID-19, Respiratory, HIV, STD, Hepatitis, C. Diff) Percent by End-user (Hospital including reference labs, physician office labs (POL) and nursing homes, pharmacy, home use and others) in 2021
  • Competitive Analysis
    • Table 10-6: Global POC Infectious Disease including COVID-19 Testing Market, Revenues and Market Share of Leading Suppliers, 2021 (in millions $)
    • Figure 10-4: Global POC Infectious Disease Test Manufacturers by Percent, 2021

Chapter 11: POC Lipid Testing
  • Products
  • Market Size and Growth
    • Table 11-1: Global POC Lipid Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
    • Figure 11-1: POC Lipid Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2021
  • POC Lipid Self-Testing
    • Table 11-2: POC Lipid Self-Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • POC Lipid Professional Testing
    • Table 11-3: POC Lipid Professional Testing Market Analysis, 2021-2026(in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
    • Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2021 (in millions $)
    • Figure 11-2: Global POC Lipid Testing Manufacturers by Percent, 2021

Chapter 12: POC Cancer Tumor Marker Testing
  • Products
    • Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
  • Market Size and Growth
    • Table 12-2: Global POC Cancer Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
    • Figure 12-1: POC Cancer Tumor Marker Testing Regional (US, Europe, Japan, Rest of World)  Market Analysis, 2021
  • COVID-19 Impact
  • Competitive Analysis
    • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 20201 (in millions $)
    • Figure 12-2: Global POC Cancer Testing Manufacturers by Percent, 2021

Chapter 13: POC Urine Testing
  • Products
  • Market Size and Growth
    • Table 13-1: Global POC Urine Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
    • Figure 13-1: POC Urine Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2021
  • POC Urine Self-Testing
    • Table 13-2: POC Urine Self-Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • POC Urine Test Professional Testing
    • Table 13-3: POC Urine Professional Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • COVID-19 Impact
  • Competitive Analysis
    • Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2021 (in millions $)
    • Figure 13-2: Global POC Urine Strip Testing Manufacturers by Percent, 2021

Chapter 14: Miscellaneous POC Testing
  • Microbiology
  • TSH
  • Allergy
  • Autoimmune
  • Others
  • Market Size and Growth
    • Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
    • Table 14-2:  Global POC Miscellaneous Sales by Test Category, 2021-2026 (Microbiology, TSH, Allergy, Autoimmune, Others TOTAL; $ millions)
  • Regional Analysis
    • Figure 14-1: POC Miscellaneous Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2021

Chapter 15: Issues and Trends
  • Overview
  • Wearables
    • Table 15-1: Selected Wearable Devices
  • Mobile Healthcare Technologies
  • Telehealth
  • Patient-centered Healthcare
  • Breath Test Advances
    • Table 15-2: Selected Disease Markers in Exhaled Breath
  • Regulatory Hurdles
  • Reimbursement Challenges
  • PAMA
  • Competition
  • POC and Molecular Diagnostics
    • Table 15-3: Selected Market Available Molecular POC Diagnostic Platforms
  • Funding Developments in POC
  • OTC tests
  • POC tests
  • POC and Biosensors and Microfluidics
    • Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2021
    • Table 15-5: Selected Biochip and Biosensor Players, 2020
  • China as a POC Market
  • Emerging POC Technologies
  • POC Connectivity
  • COVID-19 Impact
  • Multiplexed POC Testing
    • Figure 15-6: Multiplexed POC Testing Schematic
  • The Emergence of Non-invasive Technologies
  • Saliva and Swab
  • Optical Techniques
  • Near-infrared Scanning
  • Volatolomics
  • POC and Antibiotic Resistance Concerns
  • Artificial Intelligence in POC
  • POC Future in Infectious Disease Diagnostics
  • Supply Chain Delays
  • Insurance Coverage for OTC Diagnostic Tests

Chapter 16: Total Global POC Testing Market and Competitor Analysis
  • Market Overview
    • Table 16-1: Global POC Test Market, 2021-2026 (in millions $ at manufacturer level)
  • Market Analysis by Product Categories
    • Table 16-2: Global POC Testing Market Analysis by Product Category, 2021 (in millions $)
  • Market Analysis by Subcategory
  • POC Self-Testing
    • Table 16-3: Global POC Self-Testing Market Analysis by Product Category, 2021 (in millions$)
    • Figure 16-1: Global POC Self-Testing Market Analysis by Product Category, 2021(by %)
  • POC Professional Testing
    • Table 16-4: Global POC Professional Testing Market Analysis by Product Subcategory, 2021 (in millions$)
    • Figure 16-2: Global POC Professional Testing Market Analysis by Product Subcategory, 2021  (by %)
  • POC Testing by End-Use
    • Figure 16-3: POC Testing by End-user, 2021
  • Market by Device Technology
    • Figure 16-4: Global POC Market by Technology by Sales 2021
  • Market Analysis by Country
  • United States
    • Table 16-5: US POC Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • Europe
    • Table 16-6: Europe POC Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
    • Table 16-7: Global POC Testing Market Analysis by European Region, 2021 (in millions $)
  • Germany
  • France
  • UK
  • Switzerland and Sweden
  • Other
    • Figure 16-5: Europe POC Testing Percentage Participation, by Country, 2021
  • Japan
    • Table 16-8: Japan POC Testing Market Analysis, 2021-2026 (in millions of dollars at the manufacturer’s level)
  • Rest of World (RoW)
  • Latin America
  • China
  • India
  • South Korea
  • Other RoW Countries
    • Table 16-9: Global POC Testing Market Analysis by Rest of World Region/Country, 2021 (in millions $)
    • Figure 16-6: Global POC Testing Market Analysis by Rest of World Region/Country, 2021 (%)
    • Table 16-10: Global POC Testing Analysis by Region/Country, 2021 (in millions $)
    • Figure 16-7: Global POC Testing Market Analysis Percent by Region/Country, 2021
  • COVID-19 Impact
  • Competitive Analysis
    • Table 16-11: Global POC Testing Market Revenues and Market Share of Leading Suppliers, 2021 (in millions $)
    • Figure 16-8: Global POC Testing Market Share by Leading Suppliers, 2021

Chapter 17: Corporate Profiles
  • Overview
  • 1 Step Detect Associates, LLC
    • Table 17-1: 1-Step Detect Associates Corporate Summary
  • Company Overview
  • Products
  • Abbott Laboratories
    • Table 17-2: Abbott Corporate Summary
  • Company Overview
  • Alere Acquisition Update
  • Products
  • COVID-19
  • Performance Review
    • Table 17-3: Abbott Revenues 2019-2021 (in millions $)
  • Abingdon Health, Ltd.
    • Table 17-4: Abingdon Health Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • AccessBio, Inc.
    • Table 17-5: Access Bio Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • AccuBioTech Co, Ltd.
    • Table 17-6: AccuBioTech Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • ACON Laboratories, Inc
    • Table 17-7: ACON Laboratories Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Aerscher Diagnostics, LLC
    • Table 17-8: Aerscher Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Akers Biosciences, Inc.
    • Table 17-9: Akers Biosciences Corporate Summary
  • Company Overview
  • Products
  • Alfa Scientific Designs, Inc
    • Table 17-10: Alfa Scientific Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • American Bio Medica Corporation
    • Table 17-11: American Bio Medica Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • ARKRAY, Inc.
    • Table 17-12: ARKRAY Corporate Summary
  • Company Overview
  • Products
  • Artron Laboratories, Inc
    • Table 17-13: Artron Laboratories Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Ascensia Diabetes Care Holdings AG
    • Table 17-14: Ascensia Diabetes Care Corporate Summary
  • Company Overview
  • Products
  • Ativa Medical Corporation
    • Table 17-15: Ativa Medical Corporate Summary
  • Company Overview
  • Products
  • Atlas Link Biotech Co., Ltd
    • Table 17-16: Atlas Link Biotech Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Audit Diagnostics
    • Table 17-17: Audit Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Autobio Diagnostics Co., Ltd
    • Table 17-18: Autobio Diagnostics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Beckman Coulter, Inc
    • Table 17-19: Beckman Coulter Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Company Financials
    • Table 17-20: Beckman Coulter Revenue (2019-2021  ($ millions)
  • Becton Dickinson (BD)
    • Table 17-21: BD Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Company Financials
    • Table 17-22: BD Corporation Revenue (2019-2021 ($ millions)
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
    • Table 17-23:  Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Bhat Bio-Tech India Private Ltd. (BBI)
    • Table 17-24: Bhat Bio-Tech India Private Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • binx health
    • Table 17-25: binx health Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • bioLytical Laboratories
    • Table 17-26: bioLytical Laboratories Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • BioMedomics, Inc
    • Table 17-27: BioMedomics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Biomeme, Inc
    • Table 17-28: Biomeme Corporate Summary
  • Company Overview
  • Products
  • Biomerica, Inc.
    • Table 17-29: Biomerica Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Company Financials
    • Table 17-30: Biomerica Corporation Revenue (2019-2021) ($ millions)
  • bioMérieux SA
    • Table 17-31: bioMérieux SA Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Company Financials
    • Table 17-32: bioMérieux Revenues (2019-2021) ($ millions)
  • Bio-Rad Laboratories Inc.
    • Table 17-33: Bio-Rad Labs Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 17-34: Bio-Rad Corporation Revenue (2019-2021) ($ millions)
  • Biosensia Ltd.
    • Table 17-35: Biosensia Corporate Summary
  • Company Overview
  • Products
  • Biotron Diagnostics, Inc.
    • Table 17-36: Biotron Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Boditech Med Inc
    • Table 17-37: Boditech Med Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Boson Biotech Co. Ltd
    • Table 17-38: Boson Biotech Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • BTNX Inc.
    • Table 17-39: BTNX Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Calypte Biomedical Corporation
    • Table 17-40: Calypte Biomedical Corporate Summary
  • Company Overview
  • Products
  • Cepheid, Inc
    • Table 17-41: Cephid Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
    • Table 17-42: Cepheid Revenues (2019-2021) ($ millions)
  • Chembio Diagnostics, Inc.
    • Table 17-43: Chembio Diagnostic Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-44: Chembio Diagnostics Revenues (2019-2021) ($ millions)
  • Church & Dwight Co. Inc
    • Table 17-45: Church & Dwight Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-46: Church and Dwight Revenues (2019-2021 ($ millions)
  • Clarity Diagnostics, LLC
    • Table 17-47: Clarity Diagnostics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Confirm Biosciences
    • Table 17-48: Confirm Biosciences Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • CTK Biotech, Inc.
    • Table 17-49: CTK Biotech Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Danaher Corporation
    • Table 17-50: Danaher Corporation Summary
  • Company Overview
  • Products
  • Dexcom, Inc
    • Table 17-51: Dexcom Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-52: Dexcom Revenues (2019-2021) ($ millions)
  • DIALAB GmbH
    • Table 17-53: DIALAB Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • DiaSys Diagnostic Systems GmbH
    • Table 17-54: DiaSys Diagnostic Systems Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Diazyme Laboratories, Inc.
    • Table 17-55: Diazyme Laboratories Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • DNA Electronics Ltd. (DNAe)
    • Table 17-56: DNA Electronics Corporate Summary
  • Company Overview
  • Products
  • Dr. Fooke-Achterrath Laboratorien GmbH
    • Table 17-57:  Dr. Fooke-Achterrath Laboratorien Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • DxGen Corp.
    • Table 17-58:  DxGen Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Eiken Chemical Co Ltd.
    • Table 17-59: Eiken Chemical Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
    • Table 17-60:  Eiken Chemical Revenues (2019-2021 ($ millions)
  • EKF Diagnostics Holdings plc
    • Table 17-61: EKF Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-62:  EKF Diagnostics Revenues (2018-2021) ($ millions)
  • ELITechGroup, Inc.
    • Table 17-63: ELITechGroup Corporate Summary
  • Company Overview
  • Products
  • Enterix, Inc. (Clinical Genomics)
    • Table 17-64: Enterix Corporate Summary
  • Company Overview
  • Products
  • Eurobio Scientific
    • Table 17-65:  Eurobio Scientific Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Everlywell
    • Table 17-66: Everlywell Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Exact Sciences
    • Table 17-67: Exact Sciences Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-68:  Exact Sciences Revenues (2019-2021 ($ millions)
  • EY Laboratories
    • Table 17-69: EY Laboratories Corporate Summary
  • Company Overview
  • Products
  • First Check Diagnostics LLC
    • Table 17-70:  First Check Diagnostics Corporate Summary
  • Company Overview
  • Products
  • GenBio
    • Table 17-71: GenBio Corporate Summary
  • Company Overview
  • Products
  • Genedrive plc
    • Table 17-72: Genedrive Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
    • Table 17-73:  Genedrive Revenues (2019-2021) ($ millions)
  • GeTein Biotech Inc.
    • Table 17-74: GeTein Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • GlysBy diagnostics
    • Table 17-75: GlysBy Corporate Summary
  • Company Overview
  • Products
  • Helena Laboratories
    • Table 17-76: Helena Laboratories Corporate Summary
  • Company Overview
  • Products
  • Hemosure, Inc.
    • Table 17-77: Hemosure Corporate Summary
  • Company Overview
  • Products
  • HORIBA, Ltd.
    • Table 17-78: HORIBA Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-79:  HORIBA Revenues (2019-2021) ($ millions)
  • Immunosciences Lab, Inc.
    • Table 17-80: Immunosciences Lab Corporate Summary
  • Company Overview
  • Products
  • Immunostics, Inc
    • Table 17-81: Immunostics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Mitra & Co Pvt. Ltd
    • Table 17-82:  J Mitra Corporate Summary
  • Company Overview
  • Products
  • Covid-19
  • JAL Innovation PTE LTD
    • Table 17-83: JAL Innovation Corporate Summary
  • Company Overview
  • Products
  • Jant Pharmacal Corporation
    • Table 17-84: Jant Pharmacal Corporate Summary
  • Company Overview
  • Products
  • LamdaGen Corporation
    • Table 17-85: LamdaGen Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • LifeScan, Inc
    • Table 17-86: LifeScan Corporate Summary
  • Company Overview
  • Products
  • LifeSign, LLC
    • Table 17-87: LifeSign Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • LightDeck Diagnostics
    • Table 17-88: LightDeck  Diagnostics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Macherey-Nagel GmbH & Co. KG
    • Table 17-89: Macherey-Nagel Corporate Summary
  • Company Overview
  • Products
  • Medix Biochemica
    • Table 17-90: Medix Biochemica Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • MedMira, Inc
    • Table 17-91: MedMira Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
    • Table 17-92  MedMira Revenues (2019-2021) ($ thousands)
  • Medtronic, Inc.
    • Table 17-93: Medtronic Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-94:  Medtronic Revenues (2019-2021 ($ millions)
  • Menarini Diagnostics srl.
    • Table 17-95: Menarini Diagnostics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Meridian Bioscience, Inc
    • Table 17-96: Meridian Bioscience Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
    • Table 17-97:  Meridian Bioscience (2019-2021 ($ millions)
  • MiCo BioMed USA
    • Table 17-98: MiCo BioMed Summary
  • Company Overview
  • Products
  • Nano-Ditech Corporation
    • Table 17-99: Nano-Ditech Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • NG Biotech
    • Table 17-100: NG Biotech Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Noble Medical, Inc
    • Table 17-101: Noble Medical Corporate Summary
  • Company Overview
  • Products
  • Nova Biomedical Corp.
    • Table 17-102: Nova Biomedical Corporate Summary
  • Company Overview
  • Products
  • NuGenerex Diagnostics
    • Table 17-103: NuGenerex Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Oasis Diagnostics Corporation
    • Table 17-104: Oasis Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Operon S.A.
    • Table 17-105: Operon Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • OPKO Health, Inc
    • Table 17-106: OPKO Health Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
    • Table 17-107:  OPKO Health Revenues (2019-2021) ($ millions)
  • OraSure Technologies, Inc.
    • Table 17-108: OraSure Technologies Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
    • Table 17-109:  OraSure Revenues (2019-2021) ($ millions)
  • Polymedco, Inc
    • Table 17-110: Polymedco Corporate Summary
  • Company Overview
  • Products
  • Polymer Technologies, Inc (PTS Diagnostics)
    • Table 17-111: Polymer Technologies Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Preventis GmbH
    • Table 17-112: Preventis Corporate Summary
  • Company Overview
  • Products
  • Princeton Biomeditech Corporation
    • Table 17-113: Princeton Biomeditech Corporate Summary
  • Company Overview
  • Products
  • Covid-19
  • QuantuMDx Group Limited
    • Table 17-114: QuantuMDx Group Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Quidel Corporation
    • Table 17-115: Quidel Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
    • Table 17-116:  Quidel Revenues (2019-2021) ($ millions)
  • Radiometer Medical A/S
    • Table 17-117: Radiometer Medical Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-118:  Radiometer (2019-2021) ($ millions)
  • Randox Laboratories Limited
    • Table 17-119: Randox Labs Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • RENESA UG
    • Table 17-120: RENESA UG Corporate Summary
  • Company Overview
  • Products
  • Response Biomedical Corp
    • Table 17-121: Response Biomedical Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Reszon Diagnostics International Sdn. Bhd.
    • Table 17-122: Reszon Diagnostics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Rheonix, Inc
    • Table 17-123: Rheonix Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Roche Diagnostic Corporation
    • Table 17-124: Roche Diagnostic Corporate Summary
  • Company Overview
  • Products
    • Table 17-125: Roche POC  Marketed Products
  • COVID-19
  • Performance Review
    • Table 17-126:  Roche Diagnostics (2019-2021) ($ millions)
  • Savyon Diagnostics
    • Table 17-127: Savyon Diagnostics Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Sekisui Diagnostics LLC
    • Table 17-128: Sekisui Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Siemens Healthineers GmbH
    • Table 17-129: Siemens Healthineers Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
    • Table 17-130:  Siemens Healthineers (2019-2021) ($ millions)
  • Sysmex Corporation
    • Table 17-131: Sysmex Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-132: Sysmex (2019-2021) ($ millions)
  • TECHLAB, Inc.
    • Table 17-133: TECHLAB Corporate Summary
  • Company Overview
  • Products
  • Trinity Biotech PLC
    • Table 17-134: Trinity Biotech Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Performance Review
    • Table 17-135:  Trinity Biotech Revenue (2019-2021) ($ millions)
  • Trividia Health
    • Table 17-136: Trividia Health Corporate Summary
  • Company Overview
  • Products
  • Tulip Diagnostics Ltd
    • Table 17-137: Tulip Diagnostics Corporate Summary
  • Company Overview
  • Product
  • COVID-19
  • VedaLab
    • Table 17-138: VedaLab Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Veredus Laboratories PTE Ltd
    • Table 17-139: Veredus Labs Corporate Summary
  • Company Overview
  • Products
  • COVID-19
  • Werfen
    • Table 17-140:  Werfen Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-141: Werfen (2019-2021 ($ millions)

Companies Mentioned

  • 1 Step Detect Associates
  • Abbott Laboratories
  • Abingdon Health
  • Access Bio
  • AccuBioTech Co
  • ACON Laboratories
  • Aerscher Diagnostics
  • Akers Biosciences
  • Alfa Scientific Designs
  • American Bio Medica
  • ARKRAY
  • Artron Laboratories
  • Ascensia Diabetes Care
  • Ativa Medical Corp
  • Atlas Link Biotech
  • Audit Diagnostics
  • Autobio Diagnostics
  • Beckman Coulter
  • Becton Dickinson
  • Beijing Wantai Biological Pharmaceuticals
  • Bhat Bio-Tech India Private Ltd.
  • Binx health
  • bioLytical Laboratories
  • BioMedomics
  • Biomeme
  • Biomerica
  • bioMérieux SA
  • Bio-Rad Laboratories
  • Biosensia
  • Biotron Diagnostics
  • Boditech Med
  • Boson Biotech
  • BTNX
  • Calypte Biomedical Corp
  • Cepheid
  • Chembio Diagnostics
  • Church & Dwight
  • Clarity Diagnostics
  • Confirm Biosciences
  • CTK Biotech
  • Danaher Corporation
  • Dexcom
  • DIALAB
  • DiaSys Diagnostic Systems
  • Diazyme Laboratories
  • DNA Electronics Ltd. (DNAe)
  • Dr Fooke-Achterrath
  • DxGen
  • Eiken Chemical
  • EKF Diagnostics
  • ELITechGroup, Inc
  • Enterix (Clinical Genomics)
  • Eurobio Scientific
  • Everlywell
  • Exact Sciences
  • EY Laboratories
  • First Check Diagnostics
  • GenBio
  • Genedrive
  • GenePOC
  • GeTein Biotech Inc.
  • GlysBy
  • Helena Labs
  • Hemosure
  • HORIBA
  • Immunosciences Lab
  • Immunostics
  • Mitra & Co Pvt
  • JAL Innovation
  • Jant Pharmacal
  • LamdaGen Corp
  • LifeScan
  • LifeSign
  • LightDeck Diagnostics
  • Macherey-Nagel
  • Medix Biochemica
  • MedMira
  • Medtronic
  • Menarini Diagnostics
  • Meridian BioScience
  • MiCo BioMed USA
  • Nano-Ditech Corporation
  • NG Biotech
  • Noble Medical
  • Nova Biomedical
  • NuGenerex Diagnostics
  • Oasis Diagnostics
  • Operon
  • OPKO Health
  • OraSure Technologies
  • Polymedco
  • Polymer Technologies (PTS Diagnostics)
  • Preventis
  • Princeton Biomeditech
  • QuantuMDx Group
  • Quidel
  • Radiometer Medical
  • Randox Labs
  • RENESA UG
  • Response Biomedical
  • Reszon Diagnostics
  • Rheonix
  • Roche Diagnostics
  • Savyon Diagnostics
  • Sekisui Diagnostics
  • Siemens Healthcare
  • Sysmex
  • TECHLAB
  • Trinity Biotech
  • Trividia Health
  • Tulip Diagnostics
  • VedaLab
  • Veredus Laboratories
  • Werfen